Similar articles for PMID: 32817142

Year	Number of Results
1997	1
2001	1
2003	1
2004	3
2005	1
2006	4
2007	2
2009	3
2010	3
2011	3
2013	7
2014	9
2015	12
2016	10
2017	8
2018	9
2019	7
2020	14
2021	13
2022	14
2023	7
2024	0

1

Phase I Study of ^99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer.

Bragina O, von Witting E, Garousi J, Zelchan R, Sandström M, Orlova A, Medvedeva A, Doroshenko A, Vorobyeva A, Lindbo S, Borin J, Tarabanovskaya N, Sörensen J, Hober S, Chernov V, Tolmachev V. Bragina O, et al. J Nucl Med. 2021 Apr;62(4):493-499. doi: 10.2967/jnumed.120.248799. Epub 2020 Aug 17. J Nucl Med. 2021. PMID: 32817142 Free PMC article. Clinical Trial.

2

Phase I Trial of ^99mTc-(HE)₃-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer.

Bragina O, Chernov V, Schulga A, Konovalova E, Garbukov E, Vorobyeva A, Orlova A, Tashireva L, Sörensen J, Zelchan R, Medvedeva A, Deyev S, Tolmachev V. Bragina O, et al. J Nucl Med. 2022 Apr;63(4):528-535. doi: 10.2967/jnumed.121.262542. Epub 2021 Aug 12. J Nucl Med. 2022. PMID: 34385343 Free PMC article. Clinical Trial.

3

Direct In Vivo Comparison of ^99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy.

Tolmachev V, Bodenko V, Oroujeni M, Deyev S, Konovalova E, Schulga A, Lindbo S, Hober S, Bragina O, Orlova A, Vorobyeva A. Tolmachev V, et al. Int J Mol Sci. 2022 Dec 2;23(23):15181. doi: 10.3390/ijms232315181. Int J Mol Sci. 2022. PMID: 36499504 Free PMC article.

4

Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label.

Lindbo S, Garousi J, Mitran B, Altai M, Buijs J, Orlova A, Hober S, Tolmachev V. Lindbo S, et al. J Nucl Med. 2018 Jan;59(1):93-99. doi: 10.2967/jnumed.117.197202. Epub 2017 Sep 1. J Nucl Med. 2018. PMID: 28864631 Free article.

5

Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [^99mTc] Tc-Labeled Small Peptide.

Biabani Ardakani J, Abedi SM, Mardanshahi A, Shojaee L, Zaboli E, Khorramimoghaddam A, Nosrati A, Sabahno H, Banimostafavi ES, Hosseinimehr SJ. Biabani Ardakani J, et al. Clin Breast Cancer. 2023 Feb;23(2):219-230. doi: 10.1016/j.clbc.2022.12.002. Epub 2022 Dec 9. Clin Breast Cancer. 2023. PMID: 36581518

6

First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.

Sörensen J, Sandberg D, Sandström M, Wennborg A, Feldwisch J, Tolmachev V, Åström G, Lubberink M, Garske-Román U, Carlsson J, Lindman H. Sörensen J, et al. J Nucl Med. 2014 May;55(5):730-5. doi: 10.2967/jnumed.113.131243. Epub 2014 Mar 24. J Nucl Med. 2014. PMID: 24665085 Free article. Clinical Trial.

7

Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Keyaerts M, et al. J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449837 Free article. Clinical Trial.

8

Development of a ^99mTc-Labeled Single-Domain Antibody for SPECT/CT Assessment of HER2 Expression in Breast Cancer.

Zhao L, Liu C, Xing Y, He J, O'Doherty J, Huang W, Zhao J. Zhao L, et al. Mol Pharm. 2021 Sep 6;18(9):3616-3622. doi: 10.1021/acs.molpharmaceut.1c00569. Epub 2021 Jul 30. Mol Pharm. 2021. PMID: 34328338 Clinical Trial.

9

Preparation and In Vitro and In Vivo Characterization of the Tumor-specific Antigen-derived Peptide as a Potential Candidate for Targeting Human Epidermal Growth Factor Receptor 2-positive Breast Carcinomas.

Okarvi SM, Aljammaz I. Okarvi SM, et al. Anticancer Res. 2018 May;38(5):2823-2830. doi: 10.21873/anticanres.12527. Anticancer Res. 2018. PMID: 29715105

10

Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [^99mTc]-(I)-Tricarbonyl Complex.

Facca VJ, Al-Saden N, Ku A, Reilly RM. Facca VJ, et al. Mol Imaging Biol. 2021 Aug;23(4):495-504. doi: 10.1007/s11307-020-01571-z. Epub 2021 Jan 21. Mol Imaging Biol. 2021. PMID: 33479914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year